Table 1 General and clinical characteristics of studied groups

 N

21

17

21

 Male/Female (n)

16/5

9/8

13/8

 Height (m)

1.65 ± 0.09

1.62 ± 0.09

1.63 ± 0.1

0.6735

 Age (years)

54.10 ± 14.89

62.13 ± 11.78

63.00 ± 11.0

0.0642

 Previous body mass (Kg)

71.43 ± 13.32

73.50 ± 13.28

73.78 ± 13.86

0.8431

 Current body mass (Kg)

71.43 ± 13.32

69.28 ± 12.19

63.62 ± 12.90

0.1577

 Δ Body mass (Kg)^a

0.00 [0.00; 0.00]

0.00 [−7.2; 0.0]

−8.0 [−12.50;−7.0]

P < 0.0001*

 BMI (Kg/m²)

25.82 ± 3.27

25.79 ± 4.62

23.68 ± 3.49

0.1558

 C-Reactive Protein (mg/dL)

0.11 [0.0; 0.23]

0.1950 [0.0; 0.4]

1.170 [0.72; 1.3]

<0.0001***^#

 Albumin (g/dL)

4.75 [4.2; 5.1]

4.37 [4.05; 4.64]

3.84 [2.79; 4.58]

0.0037**

 Hemoglobin (g/dL)

15.25 [13.9; 15.8]

13.10 [11.30;14.08]

11.80 [9.15; 13.20]

<0.0001***^#

 IL6 (pg/ml)^a

0.00 [0.00; 0.84]

0.62 [0.00;1.77]

4.10 [1.25;9.74]

0.0008***^#

 TNFα (pg/ml)^a

5.42 [4.16; 6.15]

6.01 [3.92; 7.52]

8.82 [6.08; 13.87]

0.028**

 IL2 (pg/ml)^a

ND

ND

ND

 IL5 (pg/ml)^a

0.00 [0.00;0.73]

0.00 [0.00;0.58]

0.85 [0.00;1.36]

p < 0.0282^#

 IL8 (pg/ml)^a

0.52 [0.35;2.16]

4.79 [2.02;6.47]

28.91 [17.36;68.86]

p < 0.0001*^#

 IL13 (pg/ml)^a

0.03 [0.03;0.05]

0.04 [0.03;0.04]

0.07 [0.02;0.105]

0.2947

 IL17^b (pg/ml)^a

0.79 [0.71;1.28]

1.09 [0.79;1.41]

1.56 [0.87;2.31]

0.1305